ArticleFrontiers in immunology2026
Atypical autoimmune hepatitis presenting as acute hepatitis with prominent cholestatic features: a case report.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Autoimmune hepatitis (AIH) poses distinct diagnostic challenges due to its heterogeneous clinical presentation and lack of disease-specific features. This is further complicated by drug-induced liver injury (DILI), which can present with laboratory and histological findings indistinguishable from those of AIH. Here, we report the case of an elderly man who presented with elevated liver enzymes of unclear etiology. Initial laboratory tests showed negative antinuclear antibody (ANA) and normal serum immunoglobulin G (IgG) levels. Based on his history of consuming herbal supplements and a liver biopsy showing acute cholestatic hepatitis with cholangitis lenta, a diagnosis of DILI was initially considered. During a 1-year follow-up, two recurrent episodes of elevated liver enzymes and urine discoloration were observed. Concurrent laboratory tests revealed seroconversion to ANA positivity and an IgG level exceeding 1.2 times the upper limit of normal (ULN). A follow-up liver biopsy demonstrated typical histopathological features of AIH. In summary, repeated evaluations-including two liver biopsies and a year-long clinical follow-up-confirmed the diagnosis of AIH. This case underscores the importance of considering AIH in patients who initially present with acute hepatitis with prominent cholestatic features, even when the early clinical picture is atypical.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.